Schlagwort: NMPA
Part II: The Best Asset Doesn’t Have a Passport
For many years, Western biotech companies viewed China primarily as a manufacturing base and, increasingly, as an attractive commercial market. Today, that perspective is...
Organoids and organs on chips – an emerging biotech/pharma business
Organoids or organs-on-chips (OoCs) are two types of three-dimensional tissue culture systems amenable for the study of complex human physiological functions. Regulators increasingly recognize...